Discovery of potent dual ligands for dopamine D4 and σ1 receptors

Bioorg Med Chem. 2022 Sep 1:69:116851. doi: 10.1016/j.bmc.2022.116851. Epub 2022 Jun 20.

Abstract

During our work on exploration of molecules with some piperidine-triazole scaffolds, we realized that our compounds display chemical similarity with some σ, as well as dopaminergic receptor ligands. Here we show that this series of molecules has indeed strong affinity both for σ1 and dopamine D4 receptors. Moreover, they appear selective towards σ2, dopamine paralogues D1, D2, D3 and D5 receptors and hERG channel. Extensive molecular dynamics with our lead compound AVRM-13 were carried out on σ1, supporting agonist activity of the ligand. Unexpectedly, several observations suggested the existence of a cation binding domain, a probable regulatory site for calcium.

Keywords: Dopamine D4; Hybrids; Molecular dynamics; Molecular modelling; Piperidine; Polypharmacology; Receptor; Sigma1; Triazole.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dopamine*
  • Ligands
  • Protein Binding
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D2 / metabolism
  • Receptors, Dopamine D3 / metabolism
  • Receptors, Dopamine D4 / metabolism
  • Receptors, sigma* / metabolism

Substances

  • Ligands
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Receptors, sigma
  • Receptors, Dopamine D4
  • Dopamine